Key points are not available for this paper at this time.
Design
Review
Solidifies EP mapping as standard for SVT care; leaves open refinement for complex or novel substrates.
The introduction of programmed electrical stimulation of the heart and intracardiac activation mapping 35 years ago made it possible to study the site of origin or pathway of a supraventricular tachycardia and to gain insight into the tachycardic mechanism. Information from these studies has been the basis for the development of new therapies, like arrhythmia surgery, antitachycardia pacing, and catheter ablation. The correlation of intracardiac findings with the 12-lead ECG during the tachycardia resulted in the recognition of characteristic ECG patterns for the different types of supraventricular tachycardias. Currently, gross localization of the site of origin of the arrhythmia is based on the 12-lead ECG during the arrhythmia with fine tuning using intracardiac activation mapping and pacing. These developments during the past 3 decades make accurate arrhythmia diagnosis possible and allow us to offer curative therapies to many of patients suffering from a supraventricular tachycardia.
No takes yet. Share an insight, caveat, or question.
Hein J.J. Wellens (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: